LeonaBio, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
LeonaBio, Inc. (LONA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$105.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-31
- LeonaBio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$105.61M.
- LeonaBio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$96.91M.
- LeonaBio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$117.44M.
- LeonaBio, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$95.78M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$105.61M 10-K · filed 2026-03-31 |
| 2024-12-31 | -$96.91M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$117.44M 10-K · filed 2025-02-27 |
| 2022-12-31 | -$95.78M 10-K · filed 2024-02-22 |
| 2021-12-31 | -$54.96M 10-K · filed 2023-03-23 |
| 2020-12-31 | -$19.97M 10-K · filed 2022-03-28 |
| 2019-12-31 | -$5.16M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |